After 162 days of consolidation, the Nifty CPSE Index broke out, which was exactly what a Fibonacci time cycle said would happen. A bullish catapult on Point & Figure and strong weekly Heikin Ashi ...

Health-care companies ticked down as traders rotated into cyclical sectors. Defensive sectors such as health care had held ...

Shares of technology companies rose as traders rotated back into the sector after a volatile start to the year. Alphabet's Google is exploring new ways to expand the market for its ...

AI destroyed the market value of many software companies through forced selling. It’s driven some prominent names to multi-year lows.

After years of record highs on Wall Street powered by a narrow group of megacap tech leaders, 2026 begins with that base ...

As the market has hit new milestones, the breadth has been strong, but the leadership is wrong, Jay Woods says.

Market focus shifts toward margin durability, pipeline momentum, and valuation stability within biotechnology peers. Neurocrine Biosciences (NASDAQ:NBIX) has entered renewed market focus after a ...

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) exists to solve a specific problem: how do you gain broad exposure to pharmaceutical companies without the concentration risk of the largest healthcare ...

S&P 500 drops 0.65% as AI disruption fears hit tech stocks. Get today’s US stock market analysis with sector breakdown and ...

Rotation from growth to value is underway, with value and dividend portfolios strongly outperforming S&P 500 and Nasdaq into ...

But the volatility has been pretty extreme, as the chart below from a team of analysts at Citi Securities shows. As of the ...

Jay Woods of Freedom Capital Markets explains why tech is digesting gains after years of outperformance and highlights the ...